Tony Hitchcock | 06/03/2015
Having worked in the development and production of early stage therapeutics for over 30 years I appreciate as much as anyone that this is often a highly challenging environment, not least with regards to overcoming technical and regulatory hurdles as well as seeking to meet a highly demanding timeline.
The development of new therapeutic entities is a complex and highly demanding enterprise to undertake; especially true for small biotech companies. Such projects are multi-faceted and include m...
To continue reading this story Click Here
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3, 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
GenAI Life Science & Health 2025
September 1 - 3, 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More